» Articles » PMID: 37883058

Estimated Number of Reported Vaccine-preventable Disease Cases Averted Following the Introduction of Routine Vaccination Programs in Sweden, 1910-2019

Overview
Specialty Public Health
Date 2023 Oct 26
PMID 37883058
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Routine childhood vaccination programs have had enormous positive public health impacts worldwide. However, in some areas, these benefits may be impeded by vaccine hesitancy and undervaccination. We estimated the number of reported cases of measles, pertussis, mumps and poliomyelitis averted in Sweden after the introduction of routine childhood vaccination programs.

Methods: We used annual national data on population size and the number of reported cases of measles (1911-2019), pertussis (1911-2019), mumps (1914-2019) and poliomyelitis (1910-2019) for Sweden. For each disease, we calculated the median and 95% confidence interval of the annual pre-vaccination incidence to estimate the number of counterfactual cases; that is, the estimated number of cases that would have been observed in the post-vaccination period had no vaccine been introduced (median incidence × average annual population). For the post-vaccination periods, we calculated reported cases averted and assumed all decreases were due to vaccines.

Results: In total, for all four diseases combined, over 2.1 million cases were reported over the respective surveillance periods. Since the introduction of vaccinations, we estimate that over 1.5 million reported cases of these four diseases combined have been averted: measles (633 091), pertussis (608 670), mumps (262 951) and poliomyelitis (58 240). However, due to underreporting, especially during pre-vaccination years, these are likely underestimates.

Conclusions: Since the introduction of these routine childhood vaccination programs in Sweden, a substantial number of reported cases of vaccine-preventable diseases have been averted. Vigilance against both failure to vaccinate and undervaccination is necessary to prevent future increases of these vaccine-preventable diseases.

Citing Articles

Health Technology Assessment of Vaccines in Italy: History and Review of Applications.

Boccalini S, Ragusa R, Panatto D, Calabro G, Cortesi P, Giorgianni G Vaccines (Basel). 2024; 12(10).

PMID: 39460257 PMC: 11511491. DOI: 10.3390/vaccines12101090.

References
1.
van Panhuis W, Grefenstette J, Jung S, Chok N, Cross A, Eng H . Contagious diseases in the United States from 1888 to the present. N Engl J Med. 2013; 369(22):2152-8. PMC: 4175560. DOI: 10.1056/NEJMms1215400. View

2.
MacDonald N . Vaccine hesitancy: Definition, scope and determinants. Vaccine. 2015; 33(34):4161-4. DOI: 10.1016/j.vaccine.2015.04.036. View

3.
Patel M, Lee A, Clemmons N, Redd S, Poser S, Blog D . National Update on Measles Cases and Outbreaks - United States, January 1-October 1, 2019. MMWR Morb Mortal Wkly Rep. 2019; 68(40):893-896. PMC: 6788396. DOI: 10.15585/mmwr.mm6840e2. View

4.
Pezzotti P, Bellino S, Prestinaci F, Iacchini S, Lucaroni F, Camoni L . The impact of immunization programs on 10 vaccine preventable diseases in Italy: 1900-2015. Vaccine. 2018; 36(11):1435-1443. DOI: 10.1016/j.vaccine.2018.01.065. View

5.
van Wijhe M, Tulen A, Korthals Altes H, McDonald S, de Melker H, Postma M . Quantifying the impact of mass vaccination programmes on notified cases in the Netherlands. Epidemiol Infect. 2018; 146(6):716-722. PMC: 9134361. DOI: 10.1017/S0950268818000481. View